-
Alternative name
GCAP II, GCAP II Uroguanylin, Guanylate cyclase activator 2B, GUCA2B, UGN antibody
-
Catalog
A009293
-
Size100μg
-
Formliquid
-
Purity≥95% as determined by SDS-PAGE
-
StoragePBS with 0.02% sodium azide and 50% glycerol pH 7.3 , -20℃ for 24 months (Avoid repeated freeze / thaw cycles.)
-
ClonalityPolyclonal Antibody
-
Host Rabbit
-
Species ReactivityHuman,Mouse ,Rat
-
Applications Tested/SuitableELISA,WB,IF,IHC
-
PurificationImmunogen affinity purified
-
Immunogenguanylate cyclase activator 2B (uroguanylin)
-
IHCImmunohistochemistry of paraffin-embedded human kidney using A009293(Uroguanylin antibody) at dilution of 1:50
-
Western Blotmouse pancreas tissue were subjected to SDS PAGE followed by western blot with A009293(Uroguanylin antibody) at dilution of 1:1000
-
Recommended dilutionWB : 1:500-1:5000;IHC:1:20-1:200;IF：1:20-1:200
-
Product Description specificalUroguanylin, also named as GUCA2B, is a candidate intestinal natriuretic hormone that controls the sodium and water balance between the intestine and the kidneys. It has been reported that the uroguanylin knockout mouse exhibits elevated blood pressure. Therefore, the GUCA2B gene is thought to be a susceptibility gene for essential hypertension (EH).
-
Gene nameGUCA2B
-
locationsecreted
-
Uniprot IDQ16661
-
Calculated M.W.12kDa
-
Observed M.W.12-13 kDa
-